| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT06236139 Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With… |
Primary endpoint(s) modified |
| 2026-08-11 | NCT06492707 DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse… |
critical Recruitment suspended |
| 2026-08-11 | NCT06492707 DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse… |
critical Recruitment suspended: Recruitment on hold with plans to open to accrual again soon. |
| 2026-08-07 | NCT04994808 Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem… |
critical Trial terminated |
| 2026-08-07 | NCT04994808 Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem… |
critical Trial terminated: The study was closed due to the end of funding. |
| 2026-08-07 | NCT07731880 Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional… |
Recruitment opened |
| 2026-08-07 | NCT05874297 Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With… |
date change Primary completion pushed: 2026-11-01 -> 2027-12-31 |
| 2026-08-07 | NCT05874297 Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With… |
date change Completion pushed: 2026-11-01 -> 2027-12-31 |
| 2026-07-31 | NCT06926062 Interpersonal Communication Training and Vaccination Workflow Training Alone and in… |
Recruitment opened |
| 2026-07-25 | NCT07176000 Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal… |
Recruitment opened |
| 2026-07-25 | NCT05250037 The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After… |
overall status: Recruiting → Active, Not Recruiting |
| 2026-07-25 | NCT05250037 The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After… |
date change Primary completion pushed: 2027-12-31 -> 2028-06-30 |
| 2026-07-25 | NCT05250037 The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After… |
date change Completion pushed: 2028-06-30 -> 2028-12-31 |
| 2026-07-23 | NCT06926062 Interpersonal Communication Training and Vaccination Workflow Training Alone and in… |
date change Primary completion pushed: 2026-09-01 -> 2027-08-01 |
| 2026-07-23 | NCT06926062 Interpersonal Communication Training and Vaccination Workflow Training Alone and in… |
date change Completion pushed: 2027-10-01 -> 2027-12-01 |
| 2026-07-23 | NCT05098210 Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma… |
Enrollment increased: 25 -> 28 participants |
| 2026-07-21 | NCT06026371 Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in… |
Enrollment increased: 138 -> 157 participants |
| 2026-07-19 | NCT07645469 FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease… |
Recruitment opened |
| 2026-07-19 | NCT03399773 Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in… |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-31 | NCT07739706 A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01 | Not Yet Recruiting | |
| 2026-07-30 | NCT07737314 Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study | Not Yet Recruiting | |
| 2026-07-28 | NCT07731880 Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04409236 | Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking | Hematopoietic and Lymphoid System Neoplasm | Active, Not Recruiting |
| NCT04447313 | Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study | Obesity-Related Malignant Neoplasm | Active, Not Recruiting |
| NCT06811038 | iCanQuit Smoking Cessation Among Hispanic Adults | Cigarette Smoking-Related Carcinoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT07228624 | Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With… | Myelodysplastic/Myeloproliferative Neoplasm | Recruiting |
| NCT03970096 | Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant… | Acute Leukemia | Recruiting |
| NCT03980769 | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating… | Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder | Recruiting |
| NCT07209371 | Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of… | IgA Monoclonal Gammopathy of Undetermined Significance | Recruiting |
| NCT06839053 | Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT04941716 | Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent… | Recurrent Chronic Lymphocytic Leukemia | Recruiting |
| NCT04195633 | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for… | Acute Leukemia | Recruiting |
| NCT05996627 | Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host… | Chronic Graft Versus Host Disease | Recruiting |
| NCT05952804 | IVIG for Infection Prevention After CAR-T-Cell Therapy | Hematologic Malignancies | Recruiting |
| NCT04370301 | Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or… | Primary Myelofibrosis | Recruiting |
| NCT07046078 | Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT06013423 | Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT03779854 | Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and… | Acute Biphenotypic Leukemia | Recruiting |
| NCT06145633 | Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT06817889 | Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in… | Hematopoietic and Lymphatic System Neoplasm | Recruiting |
| NCT07011810 | Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Chronic Graft Versus Host Disease | Recruiting |
| NCT07194980 | Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory… | Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting |
| NCT04198922 | Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease | Recurrent Moderate-Severe Chronic Graft Versus Host Disease | Active, Not Recruiting |
| NCT04572815 | Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor… | Hematologic and Lymphocytic Disorder | Active, Not Recruiting |
| NCT07390968 | Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult… | Hematopoietic and Lymphatic System Neoplasm | Not Yet Recruiting |
| NCT00716066 | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | Autoimmune Disease | Active, Not Recruiting |
| NCT04384692 | Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis | Primary Myelofibrosis | Active, Not Recruiting |